Myocardial Infarction Accelerates Atherosclerosis
Authors
Affiliations
During progression of atherosclerosis, myeloid cells destabilize lipid-rich plaques in the arterial wall and cause their rupture, thus triggering myocardial infarction and stroke. Survivors of acute coronary syndromes have a high risk of recurrent events for unknown reasons. Here we show that the systemic response to ischaemic injury aggravates chronic atherosclerosis. After myocardial infarction or stroke, Apoe-/- mice developed larger atherosclerotic lesions with a more advanced morphology. This disease acceleration persisted over many weeks and was associated with markedly increased monocyte recruitment. Seeking the source of surplus monocytes in plaques, we found that myocardial infarction liberated haematopoietic stem and progenitor cells from bone marrow niches via sympathetic nervous system signalling. The progenitors then seeded the spleen, yielding a sustained boost in monocyte production. These observations provide new mechanistic insight into atherogenesis and provide a novel therapeutic opportunity to mitigate disease progression.
Innovative Atherosclerosis Models: Advancing Pathophysiology and Translational Research.
Jiang H, Liao Y, Zhu M, Jiramonai L, Wu H, Zhong Y Research (Wash D C). 2025; 8:0617.
PMID: 40046514 PMC: 11881979. DOI: 10.34133/research.0617.
Roadmap for alleviating the manifestations of ageing in the cardiovascular system.
Liberale L, Tual-Chalot S, Sedej S, Ministrini S, Georgiopoulos G, Grunewald M Nat Rev Cardiol. 2025; .
PMID: 39972009 DOI: 10.1038/s41569-025-01130-5.
Hijacking of the nervous system in cancer: mechanism and therapeutic targets.
Zhang Y, Liao Q, Wen X, Fan J, Yuan T, Tong X Mol Cancer. 2025; 24(1):44.
PMID: 39915765 PMC: 11800603. DOI: 10.1186/s12943-025-02246-5.
[Colchicine-Phoenix from the ashes].
Lunzer R, Delle-Karth G, Zeitlinger M, Prager M, Pracher L Wien Klin Wochenschr. 2025; 137(Suppl 1):1-33.
PMID: 39912853 PMC: 11802715. DOI: 10.1007/s00508-024-02490-7.
Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential.
Kohutek Z, Caslin H, Fehrenbach D, Heimlich J, Brown J, Madhur M Circ Res. 2025; 136(3):325-353.
PMID: 39883790 PMC: 11790260. DOI: 10.1161/CIRCRESAHA.124.323778.